Should You Accumulate Oramed Pharmaceuticals, Inc. (ORMP) Stock Wednesday?

Oramed Pharmaceuticals, Inc. (ORMP) stock has fallen -61.85% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives ORMP stock a score of 33 out of a possible 100.

That rank is influenced by a long-term technical score of 23. ORMP's rank also includes a short-term technical score of 39.

ORMP has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on ORMP!

See Full ORMP Report

What's Happening with ORMP Stock Today

Oramed Pharmaceuticals, Inc. (ORMP) stock is down -3.62% while the S&P 500 is up 0.21% as of 10:32 AM on Wednesday, Sep 20. ORMP has fallen -$0.10 from the previous closing price of $2.87 on volume of 86,457 shares. Over the past year the S&P 500 is higher by 15.50% while ORMP has fallen -61.85%. ORMP lost -$0.51 per share in the over the last 12 months. Click Here to get the full Stock Report for Oramed Pharmaceuticals, Inc. stock.